4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001423029-25-000003
Chief Executive Officer sold 184,298 shares at an average $67.00 ($12,348,802)
- Chief Executive Officer acquired 180,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Anzalone Christopher Richard · Chief Executive Officer
Table I: Non-derivative
13 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-12 | Grant or award : show line 1 in the form | +180,000 | 4,101,255 | D | ||
| 2025-12-15 | Sale : show line 2 in the form | −100,532 | $68.67 | $6,903,532 | 4,000,723 | D |
| 2025-12-15 | Sale : show line 3 in the form | −21,321 | $69.28 | $1,477,119 | 3,979,402 | D |
| 2025-12-15 | Sale : show line 4 in the form | −8,147 | $69.96 | $569,964 | 3,971,255 | D |
| 2025-12-16 | Sale : show line 5 in the form | −8,416 | $60.51 | $509,252 | 3,962,839 | D |
| 2025-12-16 | Sale : show line 6 in the form | −10,963 | $61.25 | $671,484 | 3,951,876 | D |
| 2025-12-16 | Sale : show line 7 in the form | −14,095 | $62.12 | $875,581 | 3,937,781 | D |
| 2025-12-16 | Sale : show line 8 in the form | −8,476 | $62.94 | $533,479 | 3,929,305 | D |
| Open-market sales · 184,298 sh · avg $67.00 · $12,348,802 | ||||||
Loading xslF345X05/wk-form4_1765908884.xml…